Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA And CMS Agree To Share Data Routinely In Step Toward Parallel Reviews

This article was originally published in The Gray Sheet

Executive Summary

Routine sharing of data between FDA and CMS will be possible for the first time under a June 23 memorandum of understanding that could serve as a first step toward parallel reviews for marketing approval and Medicare coverage
Advertisement

Related Content

A Question For Parallel Review Planners: When CMS Should Get Involved
FDA And CMS Parallel Reviews Will Begin With Device Pilot Program
Unmet Medical Needs, Regulatory Barriers Addressed In Public Comments
In Data-Sharing Pact, FDA And CMS Vow To Protect Trade Secrets
FDA Brainstorms New Regulatory Models To Address Unmet Health Needs
Major Work Ahead To Make "Mini" Sentinel System Work On A Larger Scale
Major Work Ahead To Make "Mini" Sentinel System Work On A Larger Scale
Sen. Grassley Wants FDA To Give More Info To CMS, Cites Menaflex Case
Will FDA/CMS Parallel Review Idea Make Headway This Time?
J&J Building Competitive Advantages In CMS Skills And Drug-Device Combos

Topics

Advertisement
UsernamePublicRestriction

Register

MT029052

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel